Tolerability and side-effects of post-exposure prophylaxis for HIV infection.
A study of HIV post-exposure prophylaxis in 28 recipients showed that indinavir-containing regimens were poorly tolerated. This finding has implications for compliance and efficacy of the currently recommended combinations.
Parkin
J M
JM
Murphy
M
M
Anderson
J
J
El-Gadi
S
S
Forster
G
G
Pinching
A J
AJ
D019380:Anti-HIV Agents / Q000009:adverse effects*; D004338:Drug Combinations; D004361:Drug Tolerance; D015658:HIV Infections / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D015497:HIV-1; D006801:Humans; D019469:Indinavir / Q000009:adverse effects*; D019259:Lamivudine / Q000009:adverse effects; D008131:London; D016602:Needlestick Injuries; D010349:Patient Compliance; D010564:Personnel, Hospital; D012189:Retrospective Studies; D015215:Zidovudine / Q000009:adverse effects
D019380:Anti-HIV Agents; D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir